2020 NIH Director’s Transformative Research Award (R01 - Clinical Trial Optional)

Location: n/a

Supports individuals or teams proposing projects that are inherently risky and untested but have the potential to create or overturn fundamental paradigms.

  • Open to all career stages
  • Open to individuals or teams
  • No preliminary data required
  • Flexible budget
  • See website for more information and FAQs
  • Application deadline: September 20, 2019

For more information & to apply: RFA-RM-19-007


The NIH Common Fund announces FY2020 funding opportunities for the NIH Director’s Pioneer Award, New Innovator Award, Transformative Research Award, and Early Independence Award in the High-Risk, High-Reward Research program. The program provides unique opportunities for exceptionally creative scientists to pursue highly innovative approaches to address major challenges in biomedical or behavioral research. Any research topic relevant to the broad mission of NIH is welcome. NIH especially encourages applications from women and members of groups that are underrepresented in NIH-funded research.

The High-Risk High-Reward Research Program and other Common Fund programs are managed by the Office of Strategic Coordination, Division of Program Coordination, Planning, and Strategic Initiatives in the NIH Office of the Director, in partnership with the component NIH Institutes, Centers, and Offices. The NIH Common Fund encourages collaboration and supports a series of exceptionally high impact, trans-NIH programs.

The National Institutes of Health (NIH) –“The Nation's Medical Research Agency” – includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. For more information about NIH and its programs, visit the NIH website.


« Return to Listing